Clinical Trial Results:
A PHASE IIA, RANDOMISED, SINGLE DOSE, DOUBLE-BLIND, DOUBLE-DUMMY, 6 WAY COMPLETE CROSS-OVER, PLACEBO CONTROLLED CLINICAL TRIAL TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF 4 STRENGTHS OF LAS100977 QD COMPARED TO PLACEBO AND AN ACTIVE COMPARATOR IN PATIENTS WITH STABLE MODERATE TO
SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Summary
|
|
EudraCT number |
2011-000429-58 |
Trial protocol |
DE |
Global completion date |
27 Dec 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 May 2016
|
First version publication date |
25 May 2016
|
Other versions |
|
Summary report(s) |
Synopsis-M-100977-25-Final |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.